James Warner
28
According to newly published research, Australian researchers have developed a 10-minute test that can discover cancer cells in the human body anywhere. It means there is no need to worry facing hours’ longer procedure and now thanks to a new cancer-detection advance which is able to detect traces of the disease in anyone’s bloodstream.
Australian medical experts made public announcement of the test development after researchers were finalized from the University of Queensland discovered that cancer forms a distinctive DNA structure when put in water.
It is said in statement was published in journal Nature Communications that this test works by recognizing the occurrence of that structure, a detection that could assist find out cancer in humans far in advance as compared to present methods are being used.
Professor Matt Trau mentioned in his declaration, “Discovering that cancerous DNA molecules formed entirely different 3D nanostructures from normal circulating DNA was a breakthrough that has enabled an entirely new approach to detect cancer non-invasively in any tissue type including blood,”
He continued the newly discovered test development to identify led to the formation of cheap and portable discovery equipment that could finally be part of utilization being a diagnostic device, perhaps will be available for mobile phone users.
Abu Sina, who is a co-researcher, explained the discoveries represented a “significant discovery” that will be performing its role as a “game changer” to find out cancer in any human’s body.
This test equipment will reportedly be working prominently to increase the success rate of therapeutic treatment and surgery, although Scientists all around the world have been using previous methods to detect cancer in human bodies for years.
Nevertheless, researchers from Johns Hopkins University in the United States have made public their development for a blood test this year, entitled CancerSEEK that has ability to monitor eight common cancer types. This test helps to identify the presence of cancer proteins and gene mutations in blood samples.